Primmune Therapeutics
Home - Primmune
San Diego, United States · $61.7M raised
- Headquarters
- San Diego, California
- Business Model
- B2B
- Website
- primmunerx.com
- Total Funding
- $61.7M
- Last Round
- $23.3M Series BJan 2026
- Rounds
- 3
About
Clinical-stage biotechnology company harnessing innate immunity to develop treatments for cancer and viral infections.
Summary
Primmune Therapeutics is a Biotech company based in San Diego, United States. It has raised $61.7M in total across 3 rounds, most recently a $23.3M Series B round in Jan 2026. Investors include Bioqube Ventures and OrbiMed.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...